Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

HIV prevention pills are no different. The good news is PrEP (pre-exposure prophylaxis) is extremely effective and generally ...

Black men who were identified as sexual minorities were more receptive to long-acting injectable pre-exposure prophylaxis ...

Heterosexual people with HIV-positive partners: PrEP provides protection for HIV-negative partners in serodiscordant relationships. People who inject drugs : Sharing needles increases the risk of ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it's unclear how many in the U.S. and ...

A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect ...

HIV pre-exposure prophylaxis (PrEP) coverage by geography and population among PEPFAR countries, 2022–2023. Presented at: AIDS 2024; July 22-26, 2024; Munich, Germany. Poster EPC065.

Tamar’s decision to be open about her use of PrEP is an important one, especially in light of the growing HIV rates among Black women. According to the CDC, in 2022, among females, most HIV ...

Insurance companies have to pay for PrEP under federal rules, but some skirt the requirement for free access to the treatment critical to preventing HIV.

Yeztugo (lenacapavir) will be the first option that gives people who need or want PrEP the option of injecting only twice a ...

With the FDA’s much-anticipated nod for Gilead Sciences’ long-acting HIV pre-exposure prophylaxis (PrEP) injection Yeztugo (lenacapavir), a new era of HIV prevention has dawned. | The FDA signed off ...

PrEPVacc was one of the first large, African-led HIV vaccine trials and one of the first trials to incorporate PrEP. Now it's shutting down, and no other vaccine trials are in late stages.